Digital PNG artwork · delivered by email | Secure checkout · no physical shipping
Hedi Raizer

Journal 6 min read

How does oxidative stress work?

Oxidative stress is a biochemical imbalance between reactive oxygen species and antioxidant defences. This page outlines the mechanism and summarises registered research studies that probe it in specific populations.

peptides-pro Editorial

How does oxidative stress work?

Oxidative stress is the term for a shift in the balance between reactive oxygen species (ROS) and the capacity of antioxidant systems to neutralise them. ROS include superoxide, hydrogen peroxide, hydroxyl radical and peroxynitrite; they are generated as by-products of mitochondrial electron transport, by NADPH oxidases, and by other enzymatic and non-enzymatic reactions. When ROS production exceeds the buffering capacity of glutathione, superoxide dismutase, catalase, glutathione peroxidase and dietary antioxidants, oxidative damage to lipids, proteins and DNA can follow. The concept is not a single molecule but a state, and it is measured indirectly through markers such as malondialdehyde (MDA), glutathione (GSH), and enzyme activities.

The pathway most often studied in this context is the mitochondrial electron transport chain and its relationship to redox signalling, with downstream involvement of the PI3K/Akt pathway in insulin signalling and of the glutathione peroxidase family, including GPX4, in lipid peroxide detoxification. The evidence block below does not provide a single sequence, formula or molecular weight for oxidative stress as a whole, because it is a process rather than a compound.

Research Studies

Vitamin E and oxidative stress in levothyroxine-treated hypothyroidism

A registered clinical trial is investigating whether vitamin E supplementation, given as an adjunct to levothyroxine therapy, reduces oxidative stress and improves antioxidant defence mechanisms in patients with hypothyroidism. The study aims to establish an evidence-based framework for integrating targeted antioxidant therapies into standard hypothyroid management [1]. This is a clinical study in a defined patient population; it does not establish that vitamin E is a treatment for hypothyroidism.

Zinc and insulin resistance in polyendocrine metabolic ovarian syndrome

In women with polyendocrine metabolic ovarian syndrome (PMOS), insulin resistance is a central mechanistic anchor. A registered trial is examining zinc supplementation in this population, noting that South Asian women, including Bangladeshi women, develop insulin resistance at lower BMI thresholds and carry a high burden of zinc deficiency (57% of non-pregnant, non-lactating women). Zinc is structurally required for pancreatic β-cell insulin synthesis, modulates insulin-receptor signalling and PI3K/Akt-mediated glucose uptake, and acts as a cofactor for Cu/Zn-superoxide dismutase [2]. The study is in women with PMOS; findings cannot be generalised to other groups.

Nicotinamide riboside and walking performance in peripheral artery disease

The NICE-PAD II trial is testing whether nicotinamide riboside (NR) improves or slows decline in six-minute walk distance over six months in people with peripheral artery disease (PAD) aged 50 and older. The study will randomise 250 participants to NR or placebo. Secondary outcomes include Walking Impairment Questionnaire distance score, PROMIS Mobility score, and calf muscle perfusion measured by magnetic resonance arterial spin labelling [3]. This is a clinical trial in PAD patients; it does not address oxidative stress directly as a primary endpoint.

N-acetylcysteine and repetitive behaviours in Cornelia de Lange syndrome

A randomised cross-over pilot trial is testing N-acetylcysteine (NAC) for repetitive behaviours and self-injurious behaviour in patients with Cornelia de Lange syndrome (CdLS). NAC is described as a known anti-oxidative stress and neuroprotective agent, and has shown partial response in trials for compulsive behaviours in obsessive-compulsive disorder and related disorders in autism. CdLS is a genetic disorder with autistic features, including repetitive and self-injurious behaviours [4]. This is a clinical study in a specific genetic syndrome; it does not establish NAC as a general treatment for oxidative stress.

GPX4 expression after Kono-S versus conventional anastomosis in Crohn's disease

In Crohn's disease, surgery to remove damaged intestine is often followed by recurrence near the anastomosis. A study is comparing the Kono-S anastomosis technique with conventional methods, focusing on how the bowel heals by examining oxidative stress and GPX4 expression. Early results for Kono-S are promising, but the mechanism is not fully understood [5]. This is a surgical study in Crohn's disease patients; it does not test an antioxidant supplement.

Light therapy and cellular energy in healthy adults and type 1 diabetes

A clinical trial is evaluating low-level light therapy on cellular energy and oxidative stress in healthy adults and patients with type 1 diabetes. The main questions are whether light therapy changes ATP levels and cytochrome c oxidase activity in blood cells, and how it affects oxidative stress markers, specifically glutathione and malondialdehyde concentrations. Blood samples are compared before and after therapy, and responses of healthy volunteers are compared with those of diabetic patients [6]. This is a clinical study using a device-based intervention, not a supplement.

Vitamin D and oxidative stress in diabetic peripheral neuropathy

Diabetic peripheral neuropathy (DPN) is a common complication of diabetes. Its pathogenesis is multifactorial and involves oxidative stress, chronic inflammation, endothelial dysfunction, mitochondrial injury, and microvascular ischemia. A registered trial is investigating vitamin D in this context, noting that despite symptomatic therapies such as gabapentin, pregabalin, and duloxetine, many patients continue to experience persistent symptoms [7]. This is a clinical study in DPN patients; it does not establish vitamin D as a cure for neuropathy.

Tauroursodeoxycholate and liver-targeted therapy in diabetic macular edema

Diabetic macular edema is a later-stage complication of diabetic retinopathy. Current therapies target local vascular dysfunction and provide transient improvement. A study is exploring integrative liver-targeted therapy using tauroursodeoxycholate (a bile acid) and modified traditional Chinese medicine, based on evidence linking hepatic metabolic dysfunction to neuroinflammation and vascular dysfunction in diabetic retinopathy [8]. This is a clinical study in diabetic macular edema; it does not address oxidative stress as a primary outcome.

Reference-only findings on oxidative stress mechanisms

Several reference-only papers report mechanistic findings. One study reports that ALKBH5-dependent m6A demethylation promotes cardiac aging through SLC38A3 reduction and altered glutamine metabolism [9]. A scoping review examines coffee and coffee-derived bioactive compounds in skeletal muscle health, covering mechanistic pathways, preclinical evidence and human outcomes [10]. Another paper discusses ergothioneine as a diet-derived xenobiotic, its OCTN1-mediated disposition, mitochondrial redox regulation, and implications for cardiovascular disease, noting that inconsistent results of conventional antioxidant trials may be due to compound selection, dose and other factors [11]. A further study reports that Samm50 downregulation-driven mitochondrial dysfunction triggers ferroptosis and contributes to ketamine-induced neurotoxicity and cognitive impairment [12]. These are not clinical trials of supplements in humans and are included for mechanistic context only.

If you are reading this for personal health reasons

The materials and compounds discussed on this page are sold for laboratory research use only. We do not provide dosing, medical guidance, or recommendations for personal use. Anyone considering a compound for themselves should speak to a licensed clinician.

Sources

WhatsApp